Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
DICP : the Annals of Pharmacotherapy|July 1, 1990
Moricizine: a novel antiarrhythmic agentC A Carnes, J D CoylePharmacotherapy|January 1, 1992
Evaluation of very rapid emit Qst methods for measuring serum procainamide and N-acetylprocainamide concentrationsC A Carnes, J D CoylePharmacotherapy|May 1, 1997
Evaluation of an open-loop, computer-based infusion system designed to achieve a series of constant, targeted plasma procainamide concentrations in patients undergoing electrophysiologic testingJ D Coyle, C A Carnes, S F SchaalJournal of Cardiovascular Pharmacology|August 1, 1992
Electrophysiologic interactions of procainamide and N-acetylprocainamide in isolated canine cardiac Purkinje fibersJ D Coyle, C A Carnes, S F Schaal, et al.Journal of Cardiovascular Pharmacology|September 7, 2000
Effects of azimilide, acidemia, and the combination on defibrillation energy requirementsC A Carnes, A A MehdiradPharmacotherapy|June 10, 1998
Drug and defibrillator interactionsC A Carnes, A A Mehdirad, S D NelsonPacing and Clinical Electrophysiology : PACE|February 17, 1999
The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shockA A Mehdirad, C A Carnes, S D NelsonAnesthesiology|August 1, 1997
Effect of intravenous anesthetics on inward rectifier potassium current in rat and human ventricular myocytesC A Carnes, W W Muir, D R Van WagonerBiopharmaceutics & Drug Disposition|November 1, 1991
Acecainide pharmacokinetics in normal subjects of known acetylator phenotypeJ D Coyle, H Boudoulas, J J LimaSchweizer Archiv Fur Tierheilkunde|February 7, 2013
Myocardial expression of hyperpolarization-activated, cyclic nucleotide-gated proteins in healthy cats and cats with hypertrophic cardiomyopathyS C Riesen, K E Schober, J D Bonagura, et al.Pageof 2